Article
Clinical characteristics and whole exome sequencing in JAK2V617F- and CALR-unmutated essential thrombocythemia.
Hematology (Amsterdam, Netherlands) - 1 Dec 2026
Thammayot Siraphop, Thongkumkoon Patcharawadee, Klangjorhor Jeerawan, Panyasit Noppamas, Niprapan Piangrawee, Hantrakun Nonthakorn, Punnachet Teerachat, Piriyakhuntorn Pokpong, Rattanathammethee Thanawat, Hantrakool Sasinee, Tantiworawit Adisak, Norasetthada Lalita, Chai-Adisaksopha Chatree, Rattarittamrong Ekarat
Abstract excerpt
OBJECTIVES: The aim of this study was to characterize the clinical features and outcomes of patients with JAK2 V617F- and CALR-unmutated essential thrombocythemia (ET) and to identify potential driver mutations through whole-exome sequencing (WES). METHODS: This was a cross-sectional study including patients diagnosed with ET between 2007 and 2024. Clinical characteristics and outcomes were compared between...
Topics
Join the communities discussing this publication.
